Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A5402 pramipexole versus escitalopram for depression in adults with HIV
PACTR202509835547541Phase 2Not yet recruiting
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in major depressive disorder (MDD) comparing Pramipexole with Escitalopram (2 arms). Planned start Nov 2025; status: not yet recruiting.
02
Drugs
pramipexoleescitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on PACTR202509835547541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202509835547541.